Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.A clinical trial of BioForm Medical's facial wasting treatment Radiesse has produced positive results indicating the treatment to be effective for the majority of participants sampled.
Subscribe to our email newsletter
The results of the landmark study showed that one year after initial treatment 84% of patients were “very much improved” or “much improved” according to the global aesthetic improvement scale (GAIS) and the remaining 16% were rated as “improved”.
Facial wasting is a common problem for HIV patients treated with highly active antiretroviral therapy. The condition gives patients a “hollowed-out” look and is a visible sign that they have HIV.
“Our study results demonstrate the long-lasting benefits of Radiesse to achieve dramatic improvements in the appearance of facial wasting,” noted clinical investigator Dr Joseph Eviatar, director of Chelsea Eye and Cosmetic Surgery Associates in New York. “This improvement, which generally lasts one to two years, favorably impacts these patients’ quality of life without subjecting them to an invasive procedure.”
Further, Quality of Life data collected at 12-months follow-up indicated that 100% of patients found that Radiesse treatment had been beneficial. Additionally, 99% of patients said they were more confident about their appearance after treatment with Radiesse and would recommend treatment to others.